Using arterial phase hyperenhancement on CT instead of gadoxetic acid arterial phase enhancement may improve the diagnostic performance for hepatocellular carcinoma

BACKGROUND: The diagnostic performance for hepatocellular carcinoma (HCC) is hampered using gadoxetic acid-enhanced magnetic resonance (MR) imaging due to the high incidence of transient severe motion in arterial phase (AP). Dynamic contrast enhanced computed tomography (CT) imaging yield high detec...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Hehan, Gao, Feifei, Wei, Yi, Deng, Liping, Li, Qian, Yuan, Yuan, Zhang, Tong, Chen, Guoyong, Yao, Shan, Wei, Xiaocheng, Nie, Lisha, Song, Bin, Li, Zhenlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761133/
https://www.ncbi.nlm.nih.gov/pubmed/36544692
http://dx.doi.org/10.21037/atm-22-4968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761133/
https://www.ncbi.nlm.nih.gov/pubmed/36544692
http://dx.doi.org/10.21037/atm-22-4968

Ejemplares similares